Drugs / BG-89894
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06589596 | Jan 2025 → Sep 2027 expected | neoplasm | BeOne Medicines | Recruiting | No outcome recorded |
| Phase 1 | NCT06568614 | Oct 2024 → Apr 2026 | neoplasm | BeOne Medicines | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BG-89894 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06589596 ↗ |
| Route | Oral | “Administered orally” NCT06568614 ↗ |